BioNTech SE (BNTX)
85.04
-2.61
(-2.98%)
USD |
NASDAQ |
Nov 12, 16:00
84.66
-0.38
(-0.45%)
After-Hours: 06:32
BioNTech Price to Book Value : 1.048 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.048 |
| November 11, 2026 | 1.080 |
| November 10, 2026 | 1.075 |
| November 09, 2026 | 1.078 |
| November 06, 2026 | 1.078 |
| November 05, 2026 | 1.058 |
| November 04, 2026 | 1.118 |
| November 03, 2026 | 1.071 |
| November 02, 2026 | 1.079 |
| October 30, 2026 | 1.087 |
| October 29, 2026 | 1.098 |
| October 28, 2026 | 1.084 |
| October 27, 2026 | 1.073 |
| October 26, 2026 | 1.070 |
| October 23, 2026 | 1.086 |
| October 22, 2026 | 1.105 |
| October 21, 2026 | 1.125 |
| October 20, 2026 | 1.124 |
| October 19, 2026 | 1.099 |
| October 16, 2026 | 1.081 |
| October 15, 2026 | 1.112 |
| October 14, 2026 | 1.093 |
| October 13, 2026 | 1.097 |
| October 12, 2026 | 1.181 |
| October 09, 2026 | 1.195 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.134 |
| October 07, 2026 | 1.174 |
| October 06, 2026 | 1.180 |
| October 05, 2026 | 1.203 |
| October 02, 2026 | 1.194 |
| October 01, 2026 | 1.194 |
| September 30, 2026 | 1.211 |
| September 29, 2026 | 1.220 |
| September 28, 2026 | 1.226 |
| September 25, 2026 | 1.219 |
| September 24, 2026 | 1.228 |
| September 23, 2026 | 1.218 |
| September 22, 2026 | 1.248 |
| September 21, 2026 | 1.213 |
| September 18, 2026 | 1.189 |
| September 17, 2026 | 1.221 |
| September 16, 2026 | 1.186 |
| September 15, 2026 | 1.196 |
| September 14, 2026 | 1.223 |
| September 11, 2026 | 1.197 |
| September 10, 2026 | 1.193 |
| September 09, 2026 | 1.214 |
| September 08, 2026 | 1.221 |
| September 04, 2026 | 1.284 |
| September 03, 2026 | 1.273 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | 13.67 |
| Mereo BioPharma Group Plc | 2.054 |
| NuCana Plc | 24.80 |
| Immatics NV | 1.993 |
Price to Book Value Related Metrics
| PS Ratio | 7.607 |
| PEG Ratio | -0.0768 |
| Price | 85.04 |
| Earnings Yield | -8.08% |
| Market Cap | 21.08B |
| PEGY Ratio | -0.0768 |